Literature DB >> 24399455

Is magnetotherapy applied to bilateral hips effective in ankylosing spondylitis patients? A randomized, double-blind, controlled study.

Yasemin Turan1, Kevser Bayraktar, Fatih Kahvecioglu, Engin Tastaban, Elif Aydin, Imran Kurt Omurlu, Isil Karatas Berkit.   

Abstract

This double-blind, randomized controlled study was conducted with the aim to investigate the effect of magnetic field therapy applied to the hip region on clinical and functional status in ankylosing spondylitis (AS) patients. Patients with AS (n = 66) who were diagnosed according to modified New York criteria were enrolled in this study. Patients were randomly divided in two groups. Participants were randomly assigned to receive magnetic field therapy (2 Hz) (n = 35), or placebo magnetic field therapy (n = 31) each hip region for 20 min. Patients in each group were given heat pack and short-wave treatments applied to bilateral hip regions. Both groups had articular range of motion and stretching exercises and strengthening exercises for surrounding muscles for the hip region as well as breathing and postural exercises by the same physical therapist. These treatment protocols were continued for a total of 15 sessions (1 session per day), and patients were examined by the same physician at months 1, 3 and 6. Visual analogue scale (VAS) pain, VAS fatigue, Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), Bath Ankylosing Spondylitis Functional Index (BASFI), Bath Ankylosing Spondylitis Metrologic Index (BASMI), DFI, Harris hip assessment index and Ankylosing Spondylitis Quality of Life scale (ASQOL) were obtained at the beginning of therapy and at month 1, month 3 and month 6 for each patient. There were no significant differences between groups in the VAS pain, VAS fatigue, morning stiffness, BASDAI, BASFI, BASMI, DFI, Harris hip assessment index and ASQoL at baseline, month 1, month 3 or month 6 (p > 0.05). Further randomized, double-blind controlled studies are needed in order to establish the evidence level for the efficacy of modalities with known analgesic and anti-inflammatory action such as magnetotherapy, particularly in rheumatic disorders associated with chronic pain.

Entities:  

Mesh:

Year:  2014        PMID: 24399455     DOI: 10.1007/s00296-013-2941-7

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  23 in total

1.  Development of the ASQoL: a quality of life instrument specific to ankylosing spondylitis.

Authors:  L C Doward; A Spoorenberg; S A Cook; D Whalley; P S Helliwell; L J Kay; S P McKenna; A Tennant; D van der Heijde; M A Chamberlain
Journal:  Ann Rheum Dis       Date:  2003-01       Impact factor: 19.103

2.  Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria.

Authors:  S van der Linden; H A Valkenburg; A Cats
Journal:  Arthritis Rheum       Date:  1984-04

3.  Gender and disease features in Moroccan patients with ankylosing spondylitis.

Authors:  Yousra Ibn Yacoub; Bouchra Amine; Assia Laatiris; Najia Hajjaj-Hassouni
Journal:  Clin Rheumatol       Date:  2011-07-28       Impact factor: 2.980

4.  A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index.

Authors:  A Calin; S Garrett; H Whitelock; L G Kennedy; J O'Hea; P Mallorie; T Jenkinson
Journal:  J Rheumatol       Date:  1994-12       Impact factor: 4.666

5.  A Turkish version of the Bath Ankylosing Spondylitis Disease Activity Index: reliability and validity.

Authors:  Yesim Akkoc; Altinay Goksel Karatepe; Servet Akar; Yesim Kirazli; Nurullah Akkoc
Journal:  Rheumatol Int       Date:  2004-01-17       Impact factor: 2.631

Review 6.  Hip disease in ankylosing spondylitis.

Authors:  Bert Vander Cruyssen; Nathan Vastesaeger; Eduardo Collantes-Estévez
Journal:  Curr Opin Rheumatol       Date:  2013-07       Impact factor: 5.006

7.  The Turkish version of the Bath Ankylosing Spondylitis Functional Index: reliability and validity.

Authors:  Huseyin T E Ozer; Tunay Sarpel; Bozkurt Gulek; Z Nazan Alparslan; Eren Erken
Journal:  Clin Rheumatol       Date:  2004-08-31       Impact factor: 2.980

8.  Costs and quality of life of patients with ankylosing spondylitis in Canada.

Authors:  Gisela Kobelt; Patrik Andlin-Sobocki; Walter P Maksymowych
Journal:  J Rheumatol       Date:  2006-02       Impact factor: 4.666

Review 9.  Physiotherapy interventions for ankylosing spondylitis.

Authors:  H Dagfinrud; T K Kvien; K B Hagen
Journal:  Cochrane Database Syst Rev       Date:  2008-01-23

10.  2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis.

Authors:  J Braun; R van den Berg; X Baraliakos; H Boehm; R Burgos-Vargas; E Collantes-Estevez; H Dagfinrud; B Dijkmans; M Dougados; P Emery; P Geher; M Hammoudeh; R D Inman; M Jongkees; M A Khan; U Kiltz; Tk Kvien; M Leirisalo-Repo; W P Maksymowych; I Olivieri; K Pavelka; J Sieper; E Stanislawska-Biernat; D Wendling; S Ozgocmen; C van Drogen; Bj van Royen; D van der Heijde
Journal:  Ann Rheum Dis       Date:  2011-06       Impact factor: 19.103

View more
  4 in total

1.  Effectiveness of pulsed electromagnetic field therapy on pain, functional status, and quality of life in patients with chronic non-specific neck pain: A prospective, randomized-controlled study.

Authors:  Merve Karakaş; Haydar Gök
Journal:  Turk J Phys Med Rehabil       Date:  2020-05-18

2.  [Long version on the S3 guidelines for axial spondyloarthritis including Bechterew's disease and early forms, Update 2019 : Evidence-based guidelines of the German Society for Rheumatology (DGRh) and participating medical scientific specialist societies and other organizations].

Authors:  U Kiltz; J Braun; A Becker; J-F Chenot; M Dreimann; L Hammel; A Heiligenhaus; K-G Hermann; R Klett; D Krause; K-F Kreitner; U Lange; A Lauterbach; W Mau; R Mössner; U Oberschelp; S Philipp; U Pleyer; M Rudwaleit; E Schneider; T L Schulte; J Sieper; A Stallmach; B Swoboda; M Winking
Journal:  Z Rheumatol       Date:  2019-12       Impact factor: 1.372

3.  Efficacy and safety of non-pharmacological and non-biological pharmacological treatment: a systematic literature review informing the 2016 update of the ASAS/EULAR recommendations for the management of axial spondyloarthritis.

Authors:  Andrea Regel; Alexandre Sepriano; Xenofon Baraliakos; Désirée van der Heijde; Jürgen Braun; Robert Landewé; Filip Van den Bosch; Louise Falzon; Sofia Ramiro
Journal:  RMD Open       Date:  2017-01-27

4.  Work-related outcomes in randomized, double blind, placebo-controlled trials in osteoarthritis - are they adequately reported in journal publications? A systematic review.

Authors:  Daniel Sowah; Flora Balat; Sebastian Straube
Journal:  J Occup Med Toxicol       Date:  2018-10-20       Impact factor: 2.646

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.